Home Devices Smartphones Enter mHealth Revolutions by Automatically Controlling Diabetes

Smartphones Enter mHealth Revolutions by Automatically Controlling Diabetes

SHARE
Smartphones Enter mHealth Revolutions by Automatically Controlling Diabetes

Researchers in the US have introduced a system that treats Type 1 diabetes spontaneously and smoothly, with the help of a smartphone, leaving constant finger pricks and manual insulin injections. Ars Technica, published citing the researchers’ report, that when joined with a small sensor and wearable insulin pump, a smartphone can fill in for a pancreas, mechanically monitoring blood-sugar levels and providing insulin as needed.

Smartphones Enter mHealth Revolutions by Automatically Controlling Diabetes

Also Read: Google to Introduce Needle-Free Device to Check Blood Sample

“We have been working on this specific artificial pancreas as it its called since 2006. We show that it is only possible, but it can run on a smartphone.”

Lead Researcher Boris Kovatchev, Director of the Centre for Diabetes Technology in the US University of Virginia. revealed. 

The system operates with a freely existing pen drive-sized blood-glucose sensor that can be wore in a variety of places on the body, such as an arm, leg or abdomen. The sensor reads blood-glucose levels after every five minutes and wirelessly reports the outcomes to a specifically designed app on a near android smartphone.

The app’s algorithm examines the information and wirelessly controls a subtle, wearable insulin pump, which can be bent to a belt or other piece of clothing. The pump has a very fine needle that carries insulin into the blood stream.

“If it is working, you do not know that it is there.”

Francis Doyle III, dean of Harvard’s Paulson School of Engineering and Applied Sciences, who is working together with Kovatchev on the system, informed.

Together, the “closed-loop” system should act just like a home thermostat, automatically detecting and regulating the temperature to match predetermined objectives. Doyle informed that the vital goal is to enable handling Type 1 diabetes easy and automatic, facilitating the routine lives of the 1.25 million people who suffer from the disease. 

The system will enter two concluding stages of international trials this year that will happen at different clinics in the US, France, Italy and the Netherlands. The US National Institutes of Health has sponsored the system by donating $12.6 million.

Also Read: Qualcomm Enters Health Business to Facilitate Breezhaler(TM) in Connectivity Inhaler Device